c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
about
Barrett's oesophagus and adenocarcinomaRisk factors for neoplastic progression in Barrett's esophagusMolecular biology of Barrett's adenocarcinoma.Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients.The HER-2/neu oncogene in tumors of the gastrointestinal tract.Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma.The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy.Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma.Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.In vivo cancer biomarkers of esophageal neoplasiaChromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinoma.Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors.Expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus and subsequent squamous cell carcinoma.Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).
P2860
Q24791935-DF253C18-1B2D-429B-B02B-B5E08F80B24AQ27002062-5B9DDF56-A437-41C0-BFBE-F7EC44DBCF70Q30327935-E1E142ED-CE49-412F-AFE5-3D5D01A04DFFQ30992830-E8D75886-0FA8-4692-8A8A-EA5970F13486Q34285753-4498D1A1-5769-4DE8-8B1D-AB373AD728B0Q34311106-3BAA9B13-42ED-4D37-9A26-16CCB3380D24Q34703662-CAE2E57B-CC58-45EA-9374-56A8009907A2Q35094666-4600D9D6-40E7-4753-9A9E-C7F642FBCB69Q35681702-74F9344D-9B2E-47AE-8BD2-748F79DB7B13Q36205260-F523EF17-1C65-409C-92E2-4B7D751CABF9Q36410392-76BD95A4-EEB5-4745-84E3-62FF4CA33E04Q37363691-91ABAC54-9406-4BB1-BA4D-A31021C47E08Q37398079-48820966-92B2-46DC-8468-D0810F0B0239Q37522215-C1796F58-7CBE-4F3A-AFA6-3B673EA3068FQ51103473-81FC71D7-16BC-4A91-AC19-11F4176EFDC8Q52297317-4EFA1124-55AE-4EA2-92B8-01B109C93826Q53453696-884234FF-CC70-428B-A89A-75BAC49A7260Q53754804-3E58B338-3FC1-4041-8879-9F2C5909E257
P2860
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1995
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@en
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@nl
type
label
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@en
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@nl
prefLabel
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@en
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@nl
P2093
P2860
P356
P1476
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
@en
P2093
Alderson D
Hardwick RH
Moorghen M
Newcomb PV
Shepherd NA
P2860
P304
P356
10.1136/JCP.48.2.129
P407
P577
1995-02-01T00:00:00Z